000 01581 a2200469 4500
005 20250516201158.0
264 0 _c20141014
008 201410s 0 0 eng d
022 _a1932-6203
024 7 _a10.1371/journal.pone.0089388
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJardim, Denis L
245 0 0 _aFBXW7 mutations in patients with advanced cancers: clinical and molecular characteristics and outcomes with mTOR inhibitors.
_h[electronic resource]
260 _bPloS one
_c2014
300 _ae89388 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aCell Cycle Proteins
_xgenetics
650 0 4 _aDNA Mutational Analysis
650 0 4 _aF-Box Proteins
_xgenetics
650 0 4 _aF-Box-WD Repeat-Containing Protein 7
650 0 4 _aHumans
650 0 4 _aMutation
_xgenetics
650 0 4 _aNeoplasms
_xgenetics
650 0 4 _aPhenotype
650 0 4 _aTOR Serine-Threonine Kinases
_xantagonists & inhibitors
650 0 4 _aTexas
650 0 4 _aUbiquitin-Protein Ligases
_xgenetics
700 1 _aWheler, Jennifer J
700 1 _aHess, Kenneth
700 1 _aTsimberidou, Apostolia M
700 1 _aZinner, Ralph
700 1 _aJanku, Filip
700 1 _aSubbiah, Vivek
700 1 _aNaing, Aung
700 1 _aPiha-Paul, Sarina A
700 1 _aWestin, Shannon N
700 1 _aRoy-Chowdhuri, Sinchita
700 1 _aMeric-Bernstam, Funda
700 1 _aHong, David S
773 0 _tPloS one
_gvol. 9
_gno. 2
_gp. e89388
856 4 0 _uhttps://doi.org/10.1371/journal.pone.0089388
_zAvailable from publisher's website
999 _c23601621
_d23601621